• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

Corresponding author: liuxia, 11118039@zju.edu.cn
DOI: 10.12201/bmr.202603.00041
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: [abstract missed]

    Key words: ; ; ; ; 

    Submit time: 11 March 2026

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • 叶妙淇, Liujianying, Xuyijiao, Wanglumin, Xiaxiaotong. Blood Biomarkers and VTE Risk in Cancer Patients Receiving ICIs. 2026. doi: 10.12201/bmr.202601.00053

    Houyu, Liyong, Zhouweixing, Liyaozaho, Lili. Progress in the study of cryoablation-induced immune effects and combined immunotherapy. 2025. doi: 10.12201/bmr.202503.00061

    Clinical research progress of PD-1/PD-L1 inhibitor induction therapy in unresectable stage III non-small-cell lung cancer. 2025. doi: 10.12201/bmr.202501.00025

    Yadian Lei, Haiyan Wang. The Impact of the Tumor Immune Microenvironment on T Cell Function: Focusing on the Limitations of ICB and Combined Treatment Strategies. 2024. doi: 10.12201/bmr.202412.00083

    李娜, Luo bingqing. Clinical observation of microwave ablation combined with chemotherapy and PD-1 inhibitor for non-small cell lung cancer.. 2025. doi: 10.12201/bmr.202504.00054

    liuyaru, shihao, sunguanqun, dongjingjing, yehanfeng, zhengleyi, sundan. Design and Research of Intelligent Remote Management System for Tumor Patients after Immunotherapy. 2022. doi: 10.12201/bmr.202206.00007

    Wang Huan, Ma Ying, Tian Jingnan, Lu Yi. Progress in the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Hypothyroidism from the Perspectives of Traditional Chinese and Western Medicine. 2025. doi: 10.12201/bmr.202505.00004

    Yuan Heqing, Shao Xiying. . 2025. doi: 10.12201/bmr.202504.00058

    Wang Yaoqiang, Wang Haohao, Luo Changjiang. The role of HMGB1 in the progression and therapy of Gastric Cancer. 2024. doi: 10.12201/bmr.202412.00009

    liyunkang, panyun. . 2026. doi: 10.12201/bmr.202602.00102

  • ID Submit time Number Download
    1 2026-03-03

    10.12201/bmr.202603.00041V1

    Download
  • Public  Anonymous  To author only

Get Citation

liuxia. [title missed]. 2026. biomedRxiv.202603.00041

Article Metrics

  • Read: 31
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误